Total revenue fell 4% year over year; DXC expects organic revenue to drop about 6% next quarter from a year earlier.

DXC Technology reported Q2 FY27 revenue of $7.45 billion, down 4% YoY, with adjusted EBIT margin of 6.2% and non-GAAP EPS of $0.15. The company expects Q3 organic revenue to drop 6% YoY. CEO Raul Fernandez highlighted progress in AI-based solutions. DXC also announced potential sale of its insurance business. Full-year revenue is projected to decline 5-5.5% YoY. (299 characters)

Original reporting
Published Oct 29, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$DXC
Bearish
high confidence
Mentioned
$DXC
Relevance
9/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$DXCBearishHigh
01

Why it matters

The earnings miss and lowered guidance are likely to trigger a sell‑off, especially given the company's size and market weight.

02

Market read

The news directly affects DXC stock and may influence the broader IT services sector.

03

What to watch

The insurance software segment posted 23% revenue growth, which may offset broader weakness if highlighted by analysts.

Relevance 9/10Novelty 9/10Timing: post‑market today

Background

DXC Technology is a leading enterprise‑technology services firm. The release includes full Q2 FY27 financials and FY guidance.

Company-level read

Ticker impact

$DXCBearishHigh confidence
Context

DXC Technology reported Q2 FY27 results showing a 4% YoY revenue decline and guidance for FY27 revenue down 5.5%‑5.0% YoY, plus an expected 6% organic revenue drop next quarter.

Expected impact

likely downside as investors price in lower revenue and weaker outlook

Evidence & confidence

The disclosed revenue decline and guidance are new primary information for a large‑cap company, prompting a sell‑off.

Market effects

Enterprise IT services sector may see broader pressure as DXC signals slower demand for managed services.

U.S. tech stocks could face modest pullback in the afternoon session.

Limited to investors tracking large‑cap IT service providers.

Counterpoint

If AI spend accelerates faster than DXC's guidance assumes, the stock could rebound on upside potential.

Key entities

  • DXC Technology

    U.S.-listed enterprise technology services provider (NYSE:DXC).

  • Raul Fernandez

    CEO of DXC Technology, quoted in the release.

Related articles

$DXCHighAI 8/10

What DXC Technology (DXC) Said on Its Q2 Earnings Call

DXC Technology reported Q2 earnings, with CES revenue down 3.3% YoY and GIS revenue down 10%. Insurance revenue grew 23% YoY, driven by a one-time contract. DXC reduced its fiscal 2027 outlook, expecting full-year organic revenue to decline 5% to 5.5% YoY. The company generated $91M in free cash flow, excluding a $122M tax-related payment. DXC is focusing on AI and cybersecurity growth.

$DXCHighAI 8/10

DXC Technology Co (DXC) (Q2 2027) Earnings Call Highlights: Revenue Beats Guidance

DXC Technology (DXC) reported Q2 2027 revenue beating guidance but lowered full-year revenue outlook to a 5-5.5% decline due to weak bookings and pipeline conversion. Adjusted EBIT margin fell to 6.2%, and non-GAAP EPS dropped to $0.67. The company faces deal delays and increased competition, particularly in the Americas and UKI. DXC is taking cost actions to protect margins but revenue decline may pressure future profitability.

$DXCHighAI 9/10

Why is DXC Technology stock tumbling today?

DXC Technology (DXC) stock fell 12.3% in pre-market trading after reporting mixed Q2 results. While EPS ($0.67) and revenue ($3.03B) beat estimates, the company lowered FY2027 guidance, citing weak demand and execution issues. CEO Raul Fernandez attributed some weakness to 'sales execution.' Susquehanna maintained a Neutral rating with a $12 price target. The stock traded at $13.35, nearing its 52-week low.